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The use of microorganisms in the solution of biological and
chemical problems was conceived and actually practised by Pasteur. His
separation of the optical isomers of tartaric acid by utilizing knowlege
of bacterial physiology showed the wide applicability of this concept.
Recently Dubos induced living organisms to produce specific therapeu-
tically effective enzymes forpneumococcal polysaccharides. He also used
a bacterial system to solve adifficult chemical problem in the determina-
tion of creatinine. These successes led to the search for microbiological
agents which could destroy pathogenic organisms. Gramicidin was thus
discovered and gave impetus to subsequent work in antibiotics. Dubos
early expressed the hope that in isolating biologically active substances
from bacteria, an understanding of their chemical structure and mechan-
isms of action would provide a new basis for the rational development
of therapeutic substances.1"
It has occurred to a number of investigators that new antiprotozoan
agents could be discovered by seeking natural bacterial antagonists to
protozoa.16' 30 They were able to determine the species of bacteria, and,
in some cases, the particular products of these bacteria which could
destroy protozoa. In most of these cases the pigments of chromogenic
bacteria were effective, but so also were other substances including
enzymes. Prodigiosin, the red dye ofSerratia marcescens, was repeatedly
involved in antiprotozoan activity. It was briefly tested and found some-
what effective against trypanosomes in vivo.14
The medical problems of the recent war focused attention on the
fact that a reliable cure for malaria was not available.4 The chemo-
therapeutic approach to malaria had its inception in the first use of
pure quinine about 1820. In 1871 Ehrlich noticed that methylene blue
preferentially stained plasmodia in the blood stream at concentrations
which left blood corpuscles and other tissues unstained. He soon
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demonstrated the invivo effectiveness of thedye.13 From thisknowledge,
investigators at the I. G. Farben industries initiated their research on
synthetic antimalarials. The first effective agent to emerge was
plasmochin. Later the same group discovered atabrine. This was the
status of antimalarial therapy at the beginning of 1940. War-sponsored
research centered chiefly around quinoline and its analogs and brought
forth several new and more effective drugs.25
Another approach was proposed by Taliaferro and his group who
demonstrated theeffectiveness oftyrothricin againstPlasmodium gallina-
ceum.31 Unfortunately this drug has a poor therapeutic index and is
exceedingly toxic when given systemically. Penicillin, streptomycin,
and other antibiotics were tried by many investigators against various
protozoa with almost uniformly negative results. In fact, penicillin has
proved to be very helpful in the isolation of bacteria-free cultures of
protozoa."9
Thesuccessful treatmentoftrypanosomiases with arsenic was known
before the etiological agent was discovered by Bruce. Out of the vast
amount of research that followed only two compounds have emerged
to find widespread use, Bayer 205 and tryparsamide. The first is very
effective in the early stages of T. gambiense infections but less so
against T. rhodesiense.' Tryparsamide is more effective in advanced
cases, but may cause optic neuritis and profound visual disturbances.
The fact that certain strains of trypanosomes readily become arsenic- or
antimony-fast complicates treatment of this disease. The aromatic
diamidino compounds and Eagle's new arsenicals may provide the
answer to that problem, but they introduce new toxicities. Wright con-
cludes that further successes in developing more efficient compounds
for prophylactic and curative use will result in great humanitarian
benefits.35 Unlike African trypanosomiasis, there is no treatment of
value for Chagas' disease. Bayer 7602(Ac) is said to be somewhat
effective but its curative value has been challenged.2
Leishmaniasis is usually treated by pentavalent antimonials with
excellent results. In cases resistant to antimony the diamidines prove
effective; need for new treatments is not so great as it is in other
protozoan diseases.2
None of the amebocidal drugs may be regarded as truly specific,
and there is no doubt of the need for better compounds. Emetine is
effective in controlling the symptoms of acute dysentery and amebic'
abscesses, but it will not actually cure intestinal infections and is, of
course, very toxic and dangerous. Carbarsone, chiniofon, vioform and
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diodoquin are of definite value but frequently fail to effect permanent
cures.35
The remarkable properties of penicillin and of the newer antibiotics
stimulated interest in the possibilities of similar specific, effective, and
non-toxic agents for protozoan disease. The importance of the malaria
problem, the poor qualities of the amebocides, the toxicity of the
trypanocidal agents, the incurability of Chagas' disease all contribute to
the interest anddesirability of a study of antiprotozoan chemotherapeutic
agents existing among antibiotics. Dubos' work showing the practica-
bility of the "antibiotic" approach to problems of chemotherapeutics
and the existence of natural antagonists to protozoa make the ap-
proach amenable to profitable study.
Analogs of a new, effective, chemically defined agent can be
quantitatively tested to determine the nature and location of biologically
active structures. The mode of action of more effective compounds can
be a tool for the rational study of better therapeutic agents and for
possible contribution to the knowledge of cytochemistry.
In the studies of natural protozoan antagonists three possible lines
of approach were feasible. There are extracts of enzyme nature which
are quite toxic to protozoa.16 Obviously the structure of these can not
be readily elucidated or studied. Two types of chemically defined
antibiotics have the desired antiprotozoan activity.30 One group
has as its nucleus a form of the phenazine moiety. This is an interesting
structure with many possibilities but it is closely related to the already
extensively studied acridines. The second effective structure is that of
prodigiosin, a tripyrrolemethene34 which proved somewhat effective in
vivo. The apparently proved activity, the facility of its production, and
the numerous possibilities of structural analogs prompted a preferential
study of prodigiosin.
Oxygen analogs are readily available, usually soluble, and relatively
non-toxic. Published results on the effectiveness of parasorbic acid on
T. cruzi and of furacin on T. equiperdum made this direction worth
following.
Lactones and their analogs are widely distributed in nature and are
associated with a great variety of physiological phenomena. The intact
lactone structure is essential to the myocardial effect of digitalis and
the cardiotonic glycosides. Lichens, molds, and higher plants all have
numerous representatives capable of producing lactones possessing
decided antibacterial effects. One of these compounds, parasorbic acid,
has a unique specificity for the mesenchymal tissues of higher
animals.', 6, 7, 17
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Six-membered monoheterocyclic rings with an oxygen atom are
present in a large number of natural dyes, in vitamin E, in the hem-
orrhagic compound in clover, in fish poisons, in insecticides, and in
numerous alkaloids. Their common occurrence in roots, stems, leaves,
and flowers suggests a possible origin from sugars. The chemistry of
these substances has been the subject of some famous investigations.24
Synthetic analogs of some of these naturally occurring agents have
the same types of activity as do their prototypes. The simple angeli-
calactones produce definite myocardial effects and can cause systolic
standstill of the isolated frog heart. Ascorbic acid, a lactone, also has
the cardiotonic properties of angelicalactones.22
As early as 1633 the irritating properties of the Ranunculus family
were recorded in Gerarde's herbal.'5 This substance, now known as
anemonine, was recommended for the treatment of purulent ulcers
and scrofula. In 1946 investigators were still discovering new anti-
bacterial effects of this substance.' Cavallito's recent work characterizes
many antibiotic substances in higher plants as lactones, and he describes
their mode of action.7 In the work of Hauschka the mechanism of
action of lactones on higher animal tissues is shown to be somehow
involved in amino acid metabolism, probably of an anabolic nature.'7
Furan analogs of lactones are also derived from the metabolism of
the carbohydrates.24 They occur in large quantities in corn-cobs, oat-
hulls, and other plant substances. A benzofuran structure is part of
the essential makeup of the morphine molecule. Furans, especially
those with -NO2 substituents, have important antibacterial qualities
and even show some effectiveness against protozoan parasites.9''0
The pyrroles, nitrogen analogs of the furans, are also widely dis-
tributed in nature. They constitute the universally prevalent porphyrin
pigments and various plant and animal dyes. The red pigment, pro-
digiosin, was known to be antibacterial long before its pyrrole structure
was elucidated.26 Condensed pyrrole structures are found in essential
amino acids and derivatives, in plant auxins, in toad poisons, in various
alkaloids, some of which, like physostigmine, are of great pharma-
cological interest. Synthetic pyrrole analogs are frequently superior to
their natural prototypes as dyes, auxins, poisons, and anti-infective
agents.24
After preliminary trials with other technics, an in vitro assay with
T. equiperdum was adopted because of its more precise quantitative
nature and because it can be readily supported by a reproducible in
vivo infection.
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Antibacterial, antiviral, and animal toxicity studies are used to
compare the effectiveness of different chemical modifications and to
determine specificity of action.
Materialsandmethods
The in vitro assay here used was modified from Yorke's original
method.3637 38 The strain of T. equiperdum was obtained from the
National Institute of Health, Bethesda, Maryland. It was maintained
in white mice by intraperitoneal inoculation of infected blood at
frequent intervals. The inoculum was obtained from the tail of an
infected mouse and was diluted in saline in such a manner that 0.5 ml.
contained from 1,000 to 10,000 organisms. Mice so inoculated in-
variably died on the 4th or 5th day. At irregular intervals the strain
was passed through guinea-pigs by intraperitoneal inoculation of about
10,000 organisms.
The culture medium was prepared long in advance of the experi-
ment and tested for its ability to maintain growth for the desired
interval before it was actually used to evaluate a group of drugs. It
consisted of pooled human serum, obtained from the New Haven
Hospital Serology Laboratory, diluted with Ringer's glucose mixture.
The serum was centrifuged in the cold at about 2000 r.p.m. for 2
hours, the supernate was decanted and diluted with twice its volume
of special Ringer's solution made up as follows:
sodium chloride 0.7509%
potassium chloride 0.025 %
calciumchloride 0.020%
sodium bicarbonate 0.015%
glucose 0.300%
distilled water q.s.
The mixture was then Seitz-filtered and carefully inactivated at 62-63°
C. for 30 minutes. (Ten minutes were allowed for the temperature to
reach 620 C. before the 30-minute interval started.) The final pH
was 8.3-8.5. Sterile medium was stored at 20-40 C. until used. No
changes in pH or physical appearance were noted. Sterility tests were
made by incubating samples of the medium at room temperature and
at 370 C. and by inoculation of 0.1, 0.5, and 1.0 ml. amounts into
Difco brain heart infusion broth. If there was any evidence of con-
tamination, the batch was discarded.
Cultures for in vitro testing were prepared as late as possible, after
all the agents had been diluted and dispensed into tubes. A mouse at the
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height of infection, 4 days after inoculation with about 10,000 or-
ganisms, was killed with chloroform, and blood, obtained from the
heart with aseptic precautions, was diluted with an equal volume of
sterile citrated (1 per cent) Ringer's glucose solution (as prepared
above). After mixing thoroughly, 0.05 ml. were added per each 10
ml. of serum culture medium. (The citrated solution and the medium
were carefully warmed to room temperature before use.) The culture
so obtained was examined in a hemocytometer. A count of from 500
to 1500 trypanosomes permm.3 was usual. Ifthis rangewasmissed, more
of either trypanosome suspension or culture medium was added to give
the desired count. Counts of the erythrocytes were also made and were
usually found to be 10 to 20 times greater than the number of
trypanosomes. Mixtures in which this ratio could not be achieved
were discarded.
Exactly 0.1 ml. of each dilution of the drugs to be tested, made up
in distilled water, was distributed into each of two series of sterile
Wassermann tubes; 0.4 ml. of culture were then added and the mixture
thoroughly shaken. Thus, a total volume of 0.5 ml. was used. In the
case of two agents tested simultaneously, each agent was added in
0.1 ml. amounts and 0.8 ml. of culture completed the mixture.
Identical sets were incubated at 370 C. and at room temperature.
After from 18 to 20 hours incubation, each tube was shaken and its
contents examined microscopically for trypanosome content and for
hemolysis. Control tubes containing nothing but culture were examined
at the beginning and at the end of the reading period.
The agents to be tested were made up in one of three ways:
(1) aqueous solution, autoclaved in rubber-capped vaccine bottles;
(2) aqueous solution, filtered through No. 5 Chamberland filters
and transferred to sterile vaccine bottles;
(3) alcoholic solution (95 per cent ethanol), stored in cork-
stoppered flasks.
Agents readily water soluble and heat stable were made up in the
first manner; those readily water soluble and heat labile were made up
in the second way; those water insoluble in the third way. The last
group was always diluted before use to alcohol concentrations ineffective
against trypanosomes. Alcohol controls were run to determine the level
at which alcohol alone was effective. In several cases, where possible,
agents were made up in more than one of the ways indicated. No
differences in titration results were found except when very dilute
solutions were Chamberland-filtered. Evidently, significant amounts of
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some substances were removed in this manner. Filtration was avoided
wherever possible because of resulting loss of precision. For this reason
agents that are both water- and alcohol-soluble, but either very volatile
or very heat labile were made up according to the third method. In
no case was there evidence of any contamination from any of the stock
solutions when sterility tests were made in brain heart broth.
The study of in vitro activity of all agents tested was supplemented
with in vivo tests. Each of the compounds to be tested was injected in-
traperitoneally at a dose close to the maximum tolerated level into a
groupof five infected mice. Infected, untreated controls were always ob-
served under identical conditions.*
For each experiment, white mice of the same age and sex were
uniformly inoculated with one million viable trypanosomes suspended
in physiological saline. The trypanosome suspensions were made by
heart-bleeding an infected mouse at the height of its parasitemia and
immediately diluting the blood in normal saline to a level determined
by hemocytometer count at which 0.2 to 0.5 ml. contained the required
number of organisms. Experimental mice were then inoculated at a
rate of about ten mice per minute. All mice were then pooled in one
cage, with each treatment group drawn at random. Treatment usually
started within three hours of infection.
Since the survival time is directly proportional to trypanosome
count,', 2 it was evident that any trypanocidal effect would be noted
in the increased length of survival of the treated mice. Any such effect
was pursued by more intensive and varied treatments, different routes
and times of administration, adjuvants, etc. Mice surviving 21 days
were considered cured because it has been shown that the progeny of a
single trypanosome will kill a mouse in about 152 hours.8 The average
survival time of control mice was about 80 hours. Additional evidence
of cure in mice surviving 21 days was sought by inoculating their
macerated spleens into uninfected mice, which were again observed for
21 days. In cases where few or no mice survived indefinitely, the
question of a significant in vivo trypanocidal effect was approached
statistically.
Since survival times of mice in any group were not normally dis-
tributed (arithmetically), it was necessary to normalize the data by
conversion to a logarithmic scale. The distribution of survival time was
skewed in the same manner as has been described by Chen and
* All in vivo studies were done in cooperation with N. J. Giarman.
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others.8' 23 Similarly, it was readily evident that, as in most cases of
biological phenomena, normal distribution was achieved only on a
geometric scale.3 Then ordinary statistical methods could be applied.
In a technic suggested personally by C. I. Bliss, the averages of the logs
of the survival time of the controls and of each treated group were
compared. The significance of the difference between these means was
tested by the formula:
SEm sV\/'/n, + 1/n2
where SEm = standard errorofthemeans,
s = pooledvarianceof all groups (standard deviation),
n= = numberofmice in the control group,
n2 = number ofmicein thetreatedgroup.
The probability that a difference could occur by chance was determined
from the "t" table. Degrees of freedom were taken as n1 + n2- 2.
The "t" value for each group was multiplied by the SEm determined
specifically for each treatment compared with controls at the same
time under identical conditions.
For compounds which provided complete cures for more than 50
per cent of animals, at any dose range which could be achieved, the
CD50 (curative dose for 50 per cent of the animals) was determined
by the method of maximum likelihood (C. I. Bliss).
Variation in treatment schedules was determined from the un-
published toxicity studies of N. J. Giarman on the pharmacology of
these drugs. Acute toxicity was determined by inoculating small groups
of mice with two-fold increasing concentrations of the drug. After an
approximation of the toxicity had been made, much larger groups of
mice were inoculated and the LD50 dose was determined by the method
of maximum likelihood. The highest level at which no mice died was
called the tolerated dose (T). In some cases the low order of toxicity
precluded the determination of an accurate LD50 or "T." In these cases
the largest amount of drug compatible with the maximum volume that
can be given to a mouse was administered. In the cases of drugs which
have very poor in vitro activity, no extensive toxicology was done; an
approximate "T" was determined and used in the therapeutic testing.
Oncertainofthecompounds,more complex studies on electrocardiology,
electroencephalography, respiration, spasmolytic, and cardiotonic activi-
ties were carried out by members of the Pharmacology Department of
Yale University. With their kind permission, their unpublished data
will be drawn upon when pertinent to the present study.
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As an indication of specificity, trypanocidal data are compared with
the antibacterial effects of all of the compounds tested. The work on
bacteria was done in the laboratory of H. P. Treffers under contract
with the OSRD and the USPHS. All data taken from this work are
presented fromunpublished material with thepermission ofDr. Treffers.
Each compound was tested on two different organisms, a strain of
Shigella dysenteriae and one of Staphylococcus aureus. The concentra-
tions giving complete growth inhibition in 18 hours alone and in the
presence of subinhibitory levels of penicillin or iodoacetic acid were
determined by the method described by Treffers.32
The ability of each compound to change the surface tension of
distilled water was tested at two temperatures (250 C. to 260 C. and
370 C. to 380 C.) with the DuNuoy tensiometer. In keeping with the
recommendations of Rideal2" all substances were tested at a concen-
tration of 0.1 per cent.
Two testing temperatures were used to determine the different
ratios of activity of the various compounds. This difference in variability
was to be compared with different levels of trypanocidal activity at
those temperatures.
Serrratia marcescens, culture No. 990 of the Yale University De-
partment of Bacteriology culture collection, was used for the production
of the red pigment, prodigiosin. The strain was found to maintain its
colorproduction insubmerged culture in syntheticmedium. The medium
used consistedof:
potassium acid phosphate 0.15%
potassium sulfate 0.10%
diammonium citrate 0.10%
magnesiumchloride 0.01%
asparagine (Bacto) 0.50%
tap water q.s.
pH 6.53
Ten liters of this medium were distributed into each of three 5-gallon
carboys and autoclaved at 20 pounds for 2 hours. The medium was
cooled overnight to room temperature and each carboy was inoculated
with 500 ml. of a shake culture of S. marcescens grown in the same
medium.
The carboys were incubated with gentle surface aeration at room
temperature for 6 days. By that time a heavy, deep red suspension had
formed. Samples from each carboy were plated on brain heart agar at
room temperature and at 370 C. No evidence of contamination was
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found.
The cultures were then pooled and centrifuged in a Sharples
supercentrifuge at 25,000 r.p.m., at the rate of about 100 ml. per
minute. The separated organisms were resuspended in distilled water
and washed three times. The mass of solid was finally reconstituted to
200 ml., shell frozen in a methyl cellusolve dry ice mixture, and
lyophilized for 24 hours. At this time the solid formed a fine dry
powder with a wine-red color. The yield was 0.38 gm. per liter of
medium.
Prodigiosin hydrochloride was prepared in a manner modified from
Wrede's technic.34 Twenty-five grams of lyophilized S. marcescens dry
mass were shaken in a separatory funnel with 25 ml. of 10 per cent
NaOH. To the resulting suspension were added 250 ml. of 95 per cent
ethanol and 250 ml. of petroleum ether. The entire system was shaken
vigorously for 10 minutes and then allowed to stand for 2 hours. A
two-phase distribution resulted; a lower, clear orange alcohol-NaOH
layer and an upper red emulsion of petroleum ether, prodigiosin, and
cell debris. The lower layer was discarded.
Themurkyupper layerwasshaken 5 times with 50 ml. ofpetroleum
ether. Each time a little ethanol was added to help break the emulsion.
The combined ether extracts were concentrated to 50 ml. in vacuo and
finally scrubbed with 5000 ml. distilled water in 3 portions, to remove
all traces of alcohol.
The dry extract was filtered and then treated for one hour with dry
HC1 gas to form the hydrochloride salt. After allowing the mixture to
stand about 15 minutes, the solid was removed by suction filtration. The
yield was about 2 gm.
This crude prodigiosin hydrochloride was dissolved in 100 ml. of
95 per cent ethanol with gentle warming. The undissolved portion was
removed by filtration. An approximately equimolecular amount of 50
per cent aqueous dl-tartaric acid was slowly added to the solution. The
tartrate separated out as large red knobby crystals, sintering at 1750 C.
and melting at 1800 - 1820 C. The yield was about 1.8 gm.*
Other agents were synthesized or extracted by members of the
Chemistry and Pharmacology Departments of Yale University. Many
of the chemicals were obtained from commercial chemical concerns and
research laboratories. The source of each chemical substance used will
be specified when the use of the material is described.
* The preparation of prodigiosin was carried out in cooperation with N. J. Giarman.
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Experimentation andresults
The relative activities of the compounds studied are summarized in
table 1. Inhibition of trypanosomes and bacteria is recorded in terms of
dilutions of the agent in water or in a hydro-alcohol mixture. The larger
the dilution number, the more potent the inhibitor. All the zero values
represent the lowest dilution which could be tested, the limiting factor
usually being solubility or the alcohol control. Since most of the agents
were made up in 95 per cent ethanol, the lowest dilution assayable was
that equivalent to 0.5 per cent of the amount soluble in alcohol. At
370 C. more than 0.5 per cent alcohol was inhibitory. At 25° C. alcohol
inhibited above the 2 per cent level. Opposite each zero value is the
lowest dilution tested.
Antibacterial data are presented in the same way, indicating the
lowest dilutions tested when no inhibitor level could be determined.
In all cases the figure given is the dilution at which less than 0.1
per cent of the normal growth is obtained. Lower dilutions always give
less effect or absence of inhibition and hemolysis.
In the toxicity studies, accurate LD50's could be determined only
when a large group of animals was used. In the cases where only a
"T" value is given relatively few animals were used. "T" is the largest
dose at which no animals died within 24 hours. It is no indication of
delayedor cumulative toxicity. Indeed, in many cases prolonged observa-
tion of animals receiving some of the "T" doses showed definite signs of
toxicity, as may be seen by the fact that some animals so treated died
sooner than did the controls.
In the in vivo studies it was necessary to determine a satisfactory
criterion ofeffectiveness. Thepooled variance for all treatments included
those from values strongly negative to controls. These showed clearly
that the dose of drug was toxic. In almost all of such cases, the variance
wassignificantlygreater than elsewhere. Itwas evident that the measure-
ment represented a bimodal distribution around an average toxicity
superimposed on an average response to the trypanosome infection. Dr.
C. I. Bliss advised removal of these variances from the pool since they
did not measure the effect studied. When this was done, the pooled
variance proved to be satisfactorily homogeneous with the pooled
variance of the controls alone. The probability column represents a
conservative estimate of the likelihood of the result occurring by
chance. Any value of 0.05 or less can easily be considered significantly
different from the control and highly unlikely to have appeared by
chance.
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For treatments giving complete cures no average death time could
be computed. Since no control animal ever survived, the occurrence
of cure is obvious evidence of significant effect.
It will be noted that similar differences do not always provide
similar probabilities. The reason for this is found in the variation
of the size of either the control or the treated group. Although 5 mice
were usually used per group, larger numbers were sometimes tested
when some evidence of in vivo effect appeared. In such cases a difference
takes on more weight, as may be seen from the formula presented in
the section on methods.
A number of tests on most of these agents against the influenza
virus (PR-8) were perf6rmed.29 The variances were so large that in
only one case could a possible significant difference from controls be
detected. Since the details of these experiments could not in any way
indicate the relative antiviral activities of these agents, the data have
been omitted. The only statement that can be made on the subject is
that no definite antiviral (influenza) effects could be found in any
compound, with the possible exception of Y-butyrolactone. Among the
lactones having the basic A2-Y-lactone nucleus there is considerable
trypanocidal activity both in vitro and in vivo. In terms of in vitro
dilution, anemonine, pulvinic acid, and digitoxin are the most potent,
in that order, but display no evidence of in vivo effect even though rela-
tively high doses can be administered.
The synthetic 2-pentene-1,4-olid may be considered just one half
of the symmetrical anemonine molecule, but its in vitro trypanocidal
effect is only a hundredth as great. At this level it has definite in vivo
effect unobtainable with the far more potent anemonine. In this middle
range of in vitro effect, compounds have a related range of in vivo
activity. Penicillic acid, the most active of this group, gives trypanosome-
infected mice a prolongation of life which is highly significant (.001).
The effect of the next in the series, 2-pentene-1,4-olid, is significant
(.01), and the third in the descending series, 3-phenyl,2-pentene-1,4-
olid, is of borderline significance (.05-.1). It may appear that this
group, whose in vitro effectiveness lies within the range of 1 per cent
of the highly active group, acts by a different mechanism. Possibly the
higher levels of trypanocidal activity imply reactivity with host tissues
and loss of specificity. Among the almost inactive members of the A2_y_
lactone series are carolic and terrestric acids (the lichen lactone
antibiotics), the synthetic "Win 1215," and 3-methyl,5-carboxy,2-
pentene-1,4-olid. Of the entire group, only anemonine is appreciably
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active against a typical gram-positive organism. All are related by being
more effective against the gram-negative and most effective against
protozoa.
No substituent at all on the A2-Y-lactone structure is better than
almost any one tried. The exception to this is in penicillic acid. Its
activity is related, however, to a double bond in the side chain. It has
been shown that the hydrogenation of this outside unsaturated linkage
results in almost complete loss of anti-bacterial effect.5
Although ascorbic acid is structurally a A2-Y-lactone and has definite
trypanocidal activity in vitro, it actually stimulates growth in vivo.
Several workers have shown that an exacerbation of trypanosomiasis
occurs in vitamin C deficient animals when large doses of ascorbic acid
are given.2" 28 Unlike that of other lactones, the effect of ascorbic acid
can be counteracted by peroxidase.5 This probably indicates that the
chief effect is through peroxide formation.
Surface tension depression does not seen to be related to effectiveness
in this group. The least effective of the A2-Y-lactone group depressed
surface tension to a greater extent than did penicillic acid. However,
between carolic and terrestric acids, which may be considered part
of a homologous series, the one which was more surface active was also
more effective, in spite of the fact that it is a branched chain compound,
usually considered less active than straight chain homologs. Ascorbic
acid, though effective, had no influence whatever on surface tension
even at much higher concentrations than the usual 0.1 per cent at
which all compounds were tested.
The two simple lactones having the basic A3-Y-lactone structure
were relatively inactive against the protozoa. The dimethyl derivative of
the basic 3-pentene-1,4-olid has about the same trypanocidal activity as
does the parent compound, but all antibacterial activity disappears.
In this case it would seem that the activities against protozoa and
bacteria are not inherent in identical portions of the molecule.
Lying astride the Y-lactone groups is the clavacin group. Clavacin
itself, a A3 type, is by far the most active in vitro of all the Y-lactones.
In vivo it is so toxic that an effective dose level can not be attained with-
out killing the test animal. There is some indication, however, that
with, carefully repeated administrations of small non-toxic doses, a
significant in vivo effect may be achieved. Isoclavacin has the basic
A2-Y-lactone structure and about 10 per cent of the trypanocidal activity
of clavacin. The antibacterial effect is also smaller. It is interesting to
notethatwhile the action ofclavacin isgreater against thegram-positives
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TABLE 1
ACTIVITIES OF ANTIBIOTIC LACTONES AND THEIR ANALOGS
Compound Pormula TryPanosome 37°C. Sbiga alone' Staph alone'
(source) Culture 25oC. + 8u. Pen. + .01s. Pen.
inhibition' hemolyuis' + .001% sa. + .001 % a.;
Anemonine
(Bergmann)
2-pentene-
1,4-olid
(Calco,
Winthrop)
Carolic acid
(Raistrick)
Terrestric
acid
(Raistrick)
3-phenyl-2-
pentene-1,4-olid
(Winthrop)
Penicillic
acid
(Raistrick)
Ascorbic
acid
(Merck)
3 methyl-5-
carboxy -2-
pentene-1,4-olid
(Giarman)
0=
oCM3
. %
r , CCH}
a O +s
"° I 1°" gmt
LC.!O.HZCM. 0H
rc"
t o LHComb
3200000
1600000
80000
20000
160000
160000
320000
40000
80000
80000
500 0(<500)
40000 10000 1000 500
10000 2500 4000 0(<500)
5000 0(<5000) 0(<5000) 0(<5000)
0(<5000) 0(<5000) 0(<5000) 0(<5000)
10000 0(<5000)
10000 0(<5000) 0(<5000) 0(<5000)
0(<5000) 0(<5000) 5000 0(<5000)
20000 0(<5000)
0(<20000) 0(<20000) 0(<5000) 0(<5000)
5000 0(<5000) 10000 0(<5000)
5000 0(<5000)
40000 40000 10000 0(<5000)
40000 40000 40000 0(<5000)
40000 0(<5000)
4000 500 0(<1000) 0(<1000)
-2000 0(<500) 00(<1000) 0(<1000)
0(<1000) 0(<1000)
1000
1000
0(<2000)
0(<500)
0(<500)
0(<500)
0(<500)
0(<500)
0 (<500)
0(<500)
0 Dilution, one part in the number given.
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TABLE 1-Continued
Surface Mouse toxicity Treatmens of trpnosome infection in mice
SenSion um ru soote-dose . num prob - 370/250 routE evelt her mg. per kg. dheaton eect; hr bitity cured
............ .c. T=100 6 s.c. 100 qd-5x .0748 6 .2 0
P.O. L=360 44
60.0 i.p. L=-216 66
62.5 ii.v L=245 67 i.p. 100 single .2598 5 .001-.01
62.5 s.c. L=225 13
54.0
67.3
61.8
70.4
s.c. 500 single .1249 5 .05-.1 0
p.o. T=500 10 s.c. 750 single -.0820 5 .2 0
............ S.C. T=750 20 s.c. 200 qd-5x .0000 6 >.5 0
55.6 i.p. T=20 10 i.p. 20 qd-2x .1733 10 .001-.01 0
69.5
70.7 i.p. T=1500 5 i.p. 1500 single .1646 6 .01-.05 0
72.0 .
54.5 i.p. L=500 58 i.p. 100 single -.0269 5 >.5 0
58.7 i.v. L=175 15 s.c. 100 qd-5x .1088 6 .1-.2 0
t level T = tolerated dose, L=LD.5
$ effect = difference of the mean log survival time (treated minus control)YALE JOURNAL OF BIOLOGY AND MEDICINE
TABLE 1-Continued
Compound Pormula Trypatosome 37°C. Shiga alone 1 Staph alone
(source) Culture 250C. + 8u. Pen. + .01S. Pen.
___________ ________ _ inhibition hemolysis + .001 % i.a. + .001 % i.
500
500
250
250
0(<500)
0(<500)
0(<500)
0(<500)
0(<500)
0(<500)
500 2000 0(<500) 0(<500)
500 0(<250) 0(<500) 0(<500)
0(<500) 0(<500)
10000 1000 0(<500) 0(<500)
10000 1000 0(<500) 0(<500)
0(<500) 0(<500)
0(<500) 0(<500)
5000 1000 1000 0(<500)
1000 0(<500) 500 0(<500)
10000 1000 500 500
1000 0(<500) 4000 500
1000 500
500 0
100000 0(<500) 1000 500
10000 0(<500) 1000 500
100000 100000
800000 0(<125000) 200000 100000
125000 0(<125000) 100000 100000
.~~~~100 _000
10000
5000
12500
0(<5000)
5000
0(<2500)
20000
0(<5000)
500
2000
500
0(<5000)
0(<5000)
0(<5000)
0(<500)
0(<500)
0(<500)
0(<5000)
0(<5000)
0(<5000)
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Tetrahydro-
furan
(DuPont)
Tetrahydro-
furfuryl
alcohol
(Quaker)
Methyl furan
(Quaker)
Furfuryl
alcohol
(Quaker)
Furfural
(Quaker)
Furoic acid
(Quaker)
Furacin
(Eaton)
3-pentene-
1,4-olid
(Calco,
Winthrop)
2,2-dimethyl-
3-pentene-
1,4-olid
(Winthrop)
ii771lsso 0 L113
Lc142(
Il7lcsao.
( t "Cw""CO
H0-, Capion
U7I]00"
OJI7h1C4
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TABLE 1-Continued
Treatment of trypanosome infection in mice
nlm- route-dose . num- proba- le?vel ber mg. per kg. duration effect ber bility
5 i.p. 100 I single .0825 5
60.3 T=1000 8 i.p. 500 single .0027 5
62.0 1.I).
25 s.c. 75 single .0261
i.p. 150
s.c. 50
s.C. 75
i.p. 150
S.C. 50
S.C. 75
10 i.p. 30
s.c. 500
p.o. 500
single
qd-9x
qd-5x
single
qd-5x
qd-5x
single
single
single
single
qd-5x
.0818
............
.1435
............
.0465
............
............
.0929
.0467
6
5
6
10
5
6
10
10
50
9
5
5
.2
>.5
>.5
.2
........
........
.05
........
........
.5
........
........
.2
.5
19
19
0
0
0
20
10
0
33.3
10
0
100
100
0
0
Mouse toxicity Setrface
tension
170/25O
59.1
69.4
route
i.p. T=50
S.C.
i.p.
i.p.
l.p.
L=90
L-=260
L=250
T=30
51.7
55.3
56.5
62.0
65.0
72.2
P.O. TL=2500 22
60.1 i.p. L=900 66 ip. 100
62.3 i.v. L=400 57 i.v. 300YALE JOURNAL OF BIOLOGY AND MEDICINE
TABLE 1-Continued
Trypanosome 370C. Shiga alone Staph alone
Compound Pormula Culture 25CC.
(source) - + 8u. Pen. + .01u. Pe.
____________ inhibition hemolyuis + .001 % i |. + .001% i..
0
0
CM3
ok o
CH
0 00
c
H
COCM
11
HaC c CH3
CCM3
143Ct " C}
^34s
3J "
Cr^H5 Cz,
O'_ 140
10000000
10000000
100000
50000
20000
80000
20000
40000
80000
80000
0(<5000), 0(<5000) 20000 20000 5000 0(<5000)
5000 5000 5000 0(<5000)
O(<20000) O(<5000) 0(<5000) 0(<5000)
O(<SOOO) 0(<5000)
0(<5000) 0(<5000)
500000 0(<250M9) 5000 0(<5000)
25000 0(<25000) 80000 0(<5000)
0(<5000) 0(<5000)
250000 250000 0(<5000) 0(<5000)
250000 2500 0 ( (<5000) 0(<5000)
200000 0,(<20000)
200000 0(<20000)
0(<200000) 0(<200000)
0(<200000) 0(<200000)
0(<200000) 0(<200000)
0(<200000) 0(<200000)
2000
4060
500
0(<500)
1000
1000
1000
0(<1000)
0(<1000)
0(<1000)
250
Clavacin
(Vick,
Raistrick)
Isoclavacin
(Vick)
Dimethyl
isoclavacin
(Vick)
Prodigiosin
tartrate
(Rubin-
Giarman)
6 methoxy-
8-(2,5 di-
methyl pyrrl-
.1) quinoline
(Gilman)
D2
(Eastman-
Kodak)
D4
(Eastman-
Kodak)
D20
(Eastman-
Kodak)
Dimethyl
hydantoin
(DuPont)251 ANTIBIOTIC LACTONES
TABLE 1-Continued
SuWface Mouse toxicity Treatment of trpanosome infection in mice
msison
370/250 route level num- route-dose duration effect n,t- prob'- %50
ber mg. p~er kg. er bility cured
i.p. 10 single -.3043 5 .001 0
55.5 i.p. I=8.5 26 i.p. 7.5 single -.1464 5 .05 0
72.0 i.v. L=7.5 4 i.p. 5.0 single .0770 5 .3 0
i.p. 1.5 qd-5x .0889 6 .4 0
i.p.
i.v.
i.p.
i.v.
s.c.
i.V.
s.c.
s.c.
s.c.
s.c.
T=30
T=30
T=25
T=20
T=500
T=150
T=500
T=50
T=50
T=50
2
2
2
2
6
5
5
4
4
4
i.p.
i.p.
i.p.
10
10
10
i.v. 150
S.C. 500
s.c. 500
s.c. 50
s.c. 50
s.c. 50
single
single
single
q2d-2x
single
single
single
single
single
-.0617
.0330
.0000
.0241
-.0169
-.0049
.0313
.0000
.0313
5
5
6
5
6
4
4
4
4
.3 0
0
0
0
0
0
0
0
0
i.p. 100
68.8
72.0
70.2
-71.4
55.4
58.4
55.7
56.2
71.0
71.7
--------
0 5 single .0075 1 >.5 6 l.p. T=100YALE JOURNAL OF BIOLOGY AND MEDICINE
TABLE 1-Continued
Formula
aH3
0.13
0
.1 0 "
o Ooo
OH "
Trypanosome 37°C.
Culture 25°C.
inhibition
500
500
5000
5000
160000
80000
hemolysis
250
250
5000
0(<5000)
20000
0(<2500)
Shiga alone
8u. Pen.
+ .001 % i.a.
0(<500)
0(<500)
0(<500)
0(<500)
500
0(<500)
2000
4000
4000
Staph alone
+ .Olu. Pen.
+ .001% sa.
0(<500)
0(<500)
0(<500)
0(<500)
0 (<500)
0(<500)
1000
1000 1000
3200Q0 320000 0(<10000) 0(<10000)
80000 10000 0(<10000) 0(<10000)
20000 0(<10000)
0(<5000) 0(<5000) 10000 100000 0(<5000) 0(<5000)
0(<5000) 0(K5000) 0(<5000) 0(<5000)'
500 500
1000 1000 500 500-
1000 1000 500 500
0(<10000) 20000 0(<5000) 0(<5000)
0(<5000) 0(<5000) 0(<5000) 0(<5000) 10000 0(<5000)
20000 20000
50000 0(<5000)
252
Compound
(source)
Dihydro-
pyran
(DuPont)
1,5-hexanolid
(Calco)
Parasorbic
acid
(Calco)
Coumalinic
acid
(Bergmann)
Sorbic
acid
(Bergmann)
Kojic acid
(NRRL)
Meconic
acid
(Bergmann)
Coumarin
(Bergmann)
Dicoumarin
(Bergmann)
-1.
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TABLE 1-Continued
Surface Mouse toxicity Treatment of trypanosome infection in mice
tension -_ _ _ _ _ _ _ -_ _ _ _ _ _ _ _ _ _ _ _ - _ _ _ _ _-_ _ _ _ _ _ _
370/250 route level num- route-dose duration effect n U7 proba- 9*
ber mg. per kg. ber bsltty cured
51.2
52.5 i.p. T=100 5 i.p. 100 single .0058 5 >.5 0 5.5
i.v. T=100 1 54.2 ~ P.O T=2000 11
55.5
____ p.o. L=~T488 55 58.7 p.o. L=324 52 i.p. 100 single -.0077 5 >.5 0
60.3 i.v. L=305 57 i.v. 200 q2d-2x -.0428 5 .5 0
i.p. 125 single -.1808 10 .02 0
57.0 i.p. T=125 40 ip. 100 single .1478 10 .02 0
58.2 s.c. T=100 10 i.p. 50 single .0661 10 .3 0
s.c. 100 single .0410 10 .4 0
61.8
65.8
70.3
72.1
58.1
58.5
i.p.
s.c.
i.p.
i.p.
T=100
T=500
T=100
5
5
4
i.p. 100
s.c. 500
i.p. 100
single
single
single
.0191
.0138
.0031
5
5
4
0
0
0
s.c. SQO
I
253
T=500 5 single .0192 5 0 S.C.YALE JOURNAL OF BIOLOGY AND MEDICINE
TABLE 1-Continued
Trypanosome 370C. Shiga alone Staph alone
Compound Formula Culture 258C. + e
(sorice) o s +t 8s. Pen. + .001. Pan.
I 1. i~~~nhibition hemolylsis + .001%go i.o. + .001% i.a.
Win 1215
(Winthrop)
Pulvinic acid
di-lactone
(Bergmann)
Digitoxin
(Wyeth)
y-Butyro-
lactone
(Cliffs-Dow)
y-valero-
lactone
(Monsanto)
Panto-
lactone
(Merck)
a-keto, (j,
8 dimethyl
acryl) bu-
tyrolactone
(Vick)
a-keto # (di-
methylamino-
methyl) butyro-
lactone HC1
(Winthrop)
4-( AI cyclo-
hexene) -y-
butyrolac-
tone
(Bergmann)
10000
0(<5000)
800000
0(<200000)
200000
0(<50000)
1000
0(<250)
1000
0(<250)
0(<250)
0(<250)
25000
25000
0(<20000)
0(<5000)
4000
500
20000
0(<5000)
400000
0(<200000)
400000
0(<50000)
500
0(<250)
0(<250)
0(<250)
0(<250)
0(<250)
0(<25000)
0(<25000)
0(<20000)
0(<20000)
2000
500
0(<5000)
0(<5000)
0(<5000)
(<200000)
0(<200000)
0(<200000)
0(<50000)
0(<50000)
100000
500
4000
1000
250
250 250
0(<250)
0(<250)
0(<250)
0(<5000)
10000
10000
0(<5000)
5000
20000
1000
1000
i000
0(<5000)
0(<5000)
0(<5000)
0(<200000)
0(<200000)
0(<200000)
0 (<50000)
0(<50000)
0(<50000)
0(<250)
0(<250)
0(<250)
0(<250)
0(<250)
0(<250)
0(<250)
0(<250)
; (<250)
0 (<5000)
0(<5000)
0(<5000)
0(<5000)
0(<5000)
0(<5000)
500
_500
1000
254
COOCg,o
M477J
I
,'a coocaft
coocams
0
0
H3C s0
CH3 0:yj
CH3
O CCM3
NI-(HS
O IF*
v `
- .L
I
I _
IANTIBIOTIC LACTONES 255
TABLE 1-Continued
level
gv
PCIT l
num- fooute-dose duration
''
T=150
T=500 12
T=500 10
T=1000
T=1000
18
9
effect
5 s.c. 150 single .0056
i.p. 500 single -.5423
i.p. 500 single -.1275
5
5
4
probe- %
bility cured
>.001
.05-.1
0
0
0
.03
Mouse toxicity
route
Treatment of typanosome infection in mice Sur face
tenmion
370/250
61.2
65.2
56.2
63.5
62.2
65.4
56.8
69.2
S.C.
l.p.
i.v.
i.p.
i.v.
65.6 1.P. T=25 10 i.p. 10 single -.0792 71_4 i.v. T=20 10
I I
>.5
0 5YALE JOURNAL OF BIOLOGY AND MEDICINE
than against the gram-negatives, it is the activity against the former
group that disappears most completely with the shift in the double
bond. Isoclavacin reverts to the usual activity pattern of the lactones;
it is most active against gram-negatives and less so against gram-
positives. The dimethyl derivative of isoclavacin loses all activity against
both trypanosomes and bacteria.
The comparison of surface tension measurements in the clavacin
group is interestingandsuggestive. The ratios ofsurface tensionmeasure-
ments at 37° C./25° C. are 55.5/72.0, 68.8/72.0, and 70.2/71.4
for clavacin, isoclavacin, and dimethylisoclavacin respectively. The
surface effect at room temperature is negligible and equal for all three.
But the gradation of effect at 370 C. corresponds very interestingly with
the levels of biological activity of these substances.
The structural relationship between 3- and 2-pentene-1,4-olid on
one hand, and between clavacin and isoclavacin on the other is so
similar that comparisons are inevitable. In an extensive investigation
of the antibacterial activities of these compounds5 it was shown that
3-pentene is usually somewhat more active. This was related to the
superior antibacterial effect of clavacin with its double bond in the
same position. It was found here that the antibacterial activities were
of the same order, but of a somewhat variant nature. The difference
between clavacin and isoclavacin is far more striking. The trypanocidal
effect of the 2-pentene-1,4-olid is greater than that of the 3-pentene,
reversing the bond activity relationships. The different order of change
in antibacterial effect between the two sets, and the reversed nature of
the trypanocidal activity would make it appear that the nature of
clavacin's effect probably has little to do with the basic activity of the
lactone group itself. This is further borne out by toxicity comparisons.
While 2-pentene-1,4-olid is more than three times as toxic as 3-pentene,
the toxicity relations between the clavacins are reversed with respect
to the bond position.
It may be noteworthy that the difference of trypanocidal activity at
370 C. and atroom temperature is aboutten fold in the clavacin titration
while the equivalent difference with isoclavacin is only four fold,
reflecting the relative surface tension ratios. It is important, however,
that at room temperature, clavacin, with no surface-depressing effect
whatever, is still highly trypanocidal at a dilution of 1:1,000,000. This
finding is at variance with theories holding that some surface effect is
necessary before an agent can exert its characteristic biological effect.
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Among the compounds having completely saturated lactone nuclei
there is little trypanocidal activity. The most active of the group has a
A'- cyclohexene substituent in the 4- position. Since this compound
also has some effect against both gram-positive and gram-negative
bacteria, it may be assumed that the substituent itself has conferred a
type of activity not inherent in the lactone moiety itself. None of the
other saturated lactones have any activity against gram-positive or-
ganisms. Since 4-(A cyclohexene)-Y-butyrolactone is somewhat more
effective against the gram-negatives than against the gram-positives
and is far more effective against the protozoa, it might be reasoned that
there is an additive effect of two components.
Although the trypanocidal activity of Y-butyrolactone is negligible
both invitro and in vivo, it has verypronounced toxicological effects and
has an interesting type of antibacterial activity. In both mammals and
birds it causes temporary paralysis and profound respiratory embarrass-
ment, shown by N. J. Giarman in unpublished experiments to be
central in origin. Sublethal doses of this drug completely abolish cortical
activity as measured by the electroencephalogram. It will be noted that
while the effect of this drug against Shigella dysenteriae is negligible by
itself, its activity is enhanced eight-fold by sub-inhibitory amounts of
penicillin. Furtthermore, this drug gave suggestive results against the
influenza virus in vivo.29 There is no question but that Y-butyrolactone
has inherent biological activity. Some of its analogs might prove of
interest.
Gamma-valerolactone, thehomologofY-butyrolactone, is interesting
in that the addition of a single methyl group causes the loss of almost all
biological activities. The surface tension lowering effect is also sub-
stantially diminished.
Pantolactone, which in some animals has an effect equivalent to
that ofpantothenic acid, isclosely related structurally to Y-butyrolactone.
Here again the presence of two methyl groups deprives the basic moiety
of all anti-infective activity, although in this case a significant level of
surface activity remains.
The hydrogenated furans closely resemble the saturated lactones,
both in structure and in lack of trypanocidal activity. They also retain
a definite amount of surface tension effect which serves little purpose
except to produce some hemolysis of mouse erythrocytes in vitro.
Among the furans is found the most important trypanocidal com-
pound of this survey. Furacin approaches Ehrlich's conception of the
ideal drug. A single oral dose serves to cure permanently 100 per cent
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of trypanosome-infected mice. Cured mice survived for over 6 months
without any signs of recurrence of the disease. Some cured mice were
sacrificed, their spleens were macerated and injected into other mice, but
no infection developed. This can not be the result of a transfer of the
drugitselfsince the effective doseof furacin has been carefully calculated
and amouse spleen could notpossibly contain 10 per cent ofthe curative
dose level. This drug has the further advantage of being so lacking in
toxicity that no dose up to 2 grams per kilo of mouse proved toxic or
lethal when administered subcutaneously. Three grams gave some signs
of toxicity but no deaths. Three grams represented a dose exceeding 1
per cent of the body weight of the animal and is equivalent in man to
about one pound at a single injection. The antibacterial activity of
furacin, as described in the literature,9 was confirmed. Equally great
effects are found against both gram-positive and gram-negative bacteria;
but in keeping with the related compounds of the lactone series, the
antiprotozoan effect is far greater.
Although furfuryl alcohol and furfural have only about 1 per cent
of the in vitro trypanocidal activity of furacin, they also provided some
permanent cures. The trypanocidal and surface tension properties of
the two are very similar, the former effect being somewhat greater in
furfural and the latter more pronounced in furfuryl alcohol. The
antibacterial effects, however, are strikingly different; furfural is sig-
nificantly more effective. This may also be an instance in which anti-
protozoan and antibacterial activity are not related to the same portions
of the chemical structure. In this group also, the weaker antibacterial
compounds lose activity against the gram-positive organisms sooner than
against gram-negatives.
Furoic acid is ten times as potent as furfural against trypanosomes
in vitro yet no in vivo effectiveness could be demonstrated. This may be
related to its greater toxicity, precluding any high dosage schedules.
It might also be significant that its surface tension effect is markedly less
than that of the other furans.
Methyl furan retains in vitro trypanocidal effect but has no de-
tectable antibacterial effect. This again illustrates the deleterious effect
of methyl substituents in these compounds and also the fact that anti-
bacterial activity can be affected without changing trypanocidal potency.
Although the furans have some of the most pronounced surface
tension lowering effects, they are singularly nonhemolytic. Here is an
indication that something more than surface activity is involved in
hemolysis. The measure of hemolysis probably reveals more about the
inherent toxicity of those agents than is indicated by surface tension.
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The relation of toxicity to unsaturation is evident in the furans,
especiallywhen compared with the Y-lactones. The saturated compounds,
both hydrogenated furans and lactones, are lethal at levels varying from
500 to 1000 mg. per kg. The furans with two double bonds are toxic at
doses of from 30 to 260 mg. per kg. In between lie the Y-lactones with
only one double bond in their nuclei. When this bond is in the 2-3
position as in 3-pentene-1,4-olid the toxicity is relatively low-about
900 mg. per kg. When the double bond shifts to the 1-2 position as in
2-pentene-1,4-olid toxicity is more than tripled. The LD50 now lies at
about 260 mg. per kg., close to the level of the furans with two double
bonds.
The group of &-lactones is definitely trypanocidal and remarkably
specific. The naturally occurring parasorbic acid has been repeatedly in-
vestigated. Itwasshown to be active in vitro against Trypanosoma cruzi`8
and against some bacterial species.5 In vivo it selectively destroys the
mesenchymal tissueofplatyhelminths. In tissue culture it also selectively
attacks fibroblasts and other cells of mesenchymal origin, leaving
epithelial elements unaffected. It has been postulated that such a sub-
stance may appear in ageing animals and be responsible for the poor
development of connective tissue elements."7
The most actively trypanocidal member of this group is coumalinic
acid. Its in vivo effect is significant at one of the dose schedules tried.
Greater effect could probably be achieved by more careful study of its
in vivo activity, absorption, excretion, etc. Parasorbic acid is somewhat
less trypanocidal. In agreement with Hauschka's findings with T. cruzi,
the definite in vitro effect had no in vivo counterpart.
Sorbic acid is more closely related structurally to coumalinic acid
than to parasorbic acid, since it has a system of 3 conjugated double
bonds. The rupture of the ring system, however, deprives it of almost all
biological activity. It is only 3 per cent as trypanocidal as is coumalinic
acid and 6 per cent as active as parasorbic acid.
The saturated closed ring system characterized by 1,5-hexanolid is
even less active than sorbic acid. The level of trypanocidal activity in
this group seems closely related to the degree of unsaturation when
other characteristics are held constant.
Antibacterial activity in these compounds is low and difficult to
compare because of different solubility characteristics at the high con-
centrations required for bacterial inhibition. No definite surface tension
trend is apparent; the inactive 1,5-hexanolid is the most surface active
of the group.
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Coumarin and dicoumarin are lactones structurally related to this
group. Because of solubility characteristics, no extensive studies could be
made. No in vivo trypanocidal activity could be detected.
The complete inactivity of dihydropyran indicates the importance
of the carbonyl group in lactones. It is interesting to note again that the
high surface activity of dihydropyran provides neither trypanocidal nor
hemolytic effect.
Kojic and meconic acids are related both to the lactones of this
latter group and to the nonlactone portion of the clavacin moiety. They
lack significant activity. If it is not the lactone portion of clavacin that
confers activity on the whole structure, it is the relationship of that
portion to the Y-pyrone portion that results in effectiveness since the
Y-pyrone itself is quite ineffective. The greater effect of meconic acid
may be related to its greater surface activity. Kojic acid is completely
ineffectual in changing the surface tension of water.
It is possible to compare analogs in this series that are entirely
analogous except for the size of the ring nucleus. 1,4-pentanolid and
1,5-hexanolid are similar except that the former has a 5-atom ring
while the latter has a 6-atom ring. In an identical fashion, 2-pentene-1,4-
olid is analogous with parasorbic acid. In both these comparisons the in
vitro trypanocidal activity is far greater in the six-membered ring com-
pound. In both cases the surface tension depressing effect is also greater
in the six-membered ring analog. Both of the compounds having double
bonds are, of course, far more active than their saturated analogs.
The nitrogen compounds studied were too few and too dissimilar
to permit any extensive comparisons. Although prodigiosin does have
in vitro trypanocidal activity, no in vivo effect was detected. The drug
itself was so toxic and necrotizing that an extensive study seemed in-
advisable. Some of the other agents studied were also effective in vitro
but not in vivo. A more co-ordinated series of pyrrole derivatives could
not be obtained.
Undoubtedly some,of the compounds which were effective in vitro
would have appeared more active in vivo with more detailed study of
dosage. In table 1 it will be noted that in vivo tests were repeated on
many compounds with various dosing technics.
The most extensive study of the relation between the mode of drug
administration and in vivo effectiveness was made with 2-pentene-
1,4-olid (table 2). In this case the known variables definitely influenced
its effectiveness. Although the route of administration made little differ-
ence in toxicity, it is readily evident that the intraperitoneal was more
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efficacious than the subcutaneous injection. When a 100 mg. per kg.
dose was given once intraperitoneally a significant increase in survival
time was consistently obtained; yet that dose given subcutaneously was
ineffective. This difference is reasonable when it is considered that an
TABLE 2
THE EFFECT OF DOSE SCHEDULES AND SYNERGISTIC AGENTS
ON THE IN VIVO TRYPANOCIDAL ACTIVITY OF 2-PENTENE-1,4-OLID
Route
I.p.
l.p.
i.p.
i.p.
l.p.
i.v.
S.C.
S.C.
S.C.
S.C.
Dose
50
50
50
100
100
150
100
100
100
200
Duration
qd-5x
qd-5x
qd-1 lx
single
single
q2d-2x
single
qd-5x
qd-5x
single
Delay
hours
1/2
3
1/2
1/2
24
1/2
3
1/2
3
1/2
bffect
.1624
.0015
.2812
.2598
.1976
-.1488
.0827
.1119
.2102
-.3937
No.
5
6
5
5
5
5
5
6
5
6
Probability
.02-.05
>.5
.001-.01
.001-.01
.01
.05
.2-.3
.1
.001-.01
<.001
with 0.2 ml. adrenal cortical extract s.c. 1 hour after infection
(no effect alone)
i.p. 100 single 6 .1397 | 10 | .02-.05
with 400 mg./kg. dl-threonine i.p. 1 hour after infection
(no effect alone)
s.c. 100 single j 3 .1191 5
with 400 mg./kg. dl (a) amino butyric acid i.p. 1 hour after infection
(no effect alone)
s.c. | 100 single 1 .0313 5 >.5
with 400 mg./kg. dl (a) amino butyric acid i.p. 3 hours after infection
(no effect alone)
s.c. 100 single 3 .0965 7 .1-.2
*Effect = difference of the mean log survival times (treated minus control)
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intraperitoneal injection of such a small molecule is almost equivalent
to an intravenous injection. In the tissues there is a greater chance of
detoxification. The dose is obviously important since this drug is not
highly trypanocidal. When a 50 mg. per kg. dose is given intra-
peritoneally, it must be repeated under special time conditions to give
a significant result. Time is important chiefly in relation to the dose
given. When 100 mg. per kg. are given intraperitoneally even 24 hours
after the inoculation, a significant effect is noted. When treatment is
delayed three hours, subcutaneous treatment loses its value. It is
possible that the intraperitoneal route has the additional advantage of
bringing the drug into immediate contact with the organism, which
is also introduced in the same way. The same dose given 1/2 hour after
infection is far more effective than that dose given after 24 hours. Of
course, after that period of time the number of organisms has signifi-
cantly increased. An observation, not obvious from table 2, is that when
treatment is delayed, a syndrome of toxic symptoms appears unlike
those due to the drugs themselves, probably representing a form of
Herxheimer's reaction. This also appeared after repeated injections of
an effective drug. The nature of this reaction was borne out by the fact
thatthe numbersoftrypanosomes in the circulating blood decreased sud-
denly and sharply at the time of the toxic symptoms.
Repetition of an effective dose increased survival time, but even
after continuous treatment for 11 days no permanent cure resulted.
Trypanosomes from such treated mice were tested for increased drug
resistance. No differences could be found, and no detailed study was
understaken since it would have involved a long and complex study not
directly concerned with the major interests of this work.
Single doses exceeding 100 mg. per kg. were significantly toxic.
The only feasible approach to enhanced effect was by means of repeated
administration of well-tolerated amounts.
Attempts to enhance the activity of 2-pentene-1,4-olid by means
of synergistic agents produced insignificant results. Adrenal cortical
extract was administered with the hope of provoking some immune
response in time to provide synergism with the drug. No effect was
noted. The simultaneous injection of amino acids which are synergistic
in vitro, threonine and a-amino butyric acid, gave very faint, statistically
insignificant results. The fact that these amino acids are metabolized
rapidly made these tests inconclusive. Repeated administration might
prove more efficacious.
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In the cases of furfural and furfuryl alcohol large single doses pro-
vided only a prolongation of life in trypanosome-infected mice, but
repeated smaller doses did provide permanent cures.
The study of furacin is summarized in table 3. From the data it can
be found that the CD50 (curative dose) for subcutaneous administration
of this drug is 197 mg. per kg. This is a very small proportion of the
TABLE 3
THE EFFECT OF FURACIN ON T. EQUIPERDUM INFECTIONS IN MICE
Rouse Dose No. of mice Delay hours % cured
s.c. 62.5 10 1 20
s.c. 125 10 1 30
s.c. 250 10 1 60
s.c. 500 10 1/2 100
s.c. . 500 20 1 100
s.c. 500 10 24 100
s.c. 500 10 48 100
p.o. 500 9 1 100
toxic level, not achieved with 3000 mg. per kg. A complete cure could
be attained after a delay of as much as 48 hours, at which time the
blood is swarming with trypanosomes. Absorption of this drug from
the gastro-intestinal tract is sufficiently complete to provide a complete
cure at thesame level as with the subcutaneous injection. No recurrences
or signs of toxicity resulted.
Discussion
The property of growth inhibition is important from two points
of view. The fundamental problem of growth and its mechanism in-
volves the study of many substances which may or may not become
clinically useful. Although it has long been recognized that relationships
exist between the chemical structure of certain compounds and their
biological properties, these interdependences have only recently differed
from unrelated studies of empirically discovered drugs. Both for the
theoretical reasons involved in elucidating biochemical growth problems
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and for the practical one of effective chemotherapy, the nature and
mechanisms of cytochemical specificities have been deduced from the
recent work in biochemorphology. The second problem is that of
practical chemotherapy. This aspect frequently departs from the current
presentation of this subject in terms of diseases or chemical structures.
Compounds very different chemically are effective against the same
infection, and very similar chemical structures have diametrically
opposite effects. Such findings appear disorderly when chemical and
pathological disciplines are imposed upon chemotherapy. The past has
been characterized by a highly empirical approach to a subject ex-
tremely rich in theoretical associations.
As the factors conditioning pathogenesis are many, so also are the
means by which the process is open to disturbance. Actually there is
no valid study of the relations between biological activity and chemical
structure without a primary consideration of specific drug-protoplasm
interactions. Merely to know that an agent destroys an organism or
cures a disease says very little about the nature and the fundamental
biology of the reaction.
The two points of view, the fundamental and the practical, are
united in the inevitable fact that cytochemical reagents are almost
invariably toxic substances. Before they become important as therapeutic
agents, however, they must prove to be of less than general toxicity
and be capable of administration in a form not too easily inactivated
or removed from the body. To study such a problem adequately it is
necessary to interrelate the drug, the parasite, and the host.
The point of departure of the present work was a consideration of
the parasite. Interest was focussed on a new basis for the therapy
of protozoan disease. The study of other types of parasites is pertinent
here only in relating the specificities of the various drugs for different
organisms. Employing T. equiperdum helped solve some problems and
created others. Quantitative results could be derived from the successful
adaptation of Yorke's in vitro culture. Yorke's results obtained with this
method closely corresponded to in vivo effects, both qualitatively and
quantitatively, where no such correlated results had been previously
obtained with an in vitro technic. Indeed, Mcllwain declared that the
method using human serum approximated more closely practical chemo-
therapeutic conditions than did the use of some test animals. There are
many cases in which a drug cures a disease in one animal but does not
affect it in another. From some of the results of this work it is evident
that in vitro testing, even in the presence of the factors in human serum,
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is not necessarily much nearer to the conditions under which the drug
will ultimately be used. Many drugs highly active in vitro utterly failed
to provide therapeutic results. The fact that the drugs may act in the
same manner in vivo and in vitro is not conclusively disproved by such
trials. The variations in toxicity, absorption, distribution, and excretion
must be considered. The therapeutic dose of a drug required in a small
animal usually exceeds the proportional amount required in man. Other
host factors such as the presence or the requirements of metabolites
havebeen shown toinfluence theeffectivenessof adrug. McIlwainpoints
out that in vitro and in vivo examinations are complementary; the
use ofin vivo testing in selecting agents suitable for further examination
isvaluable, though in vitro studies have an analytical importance beyond
this.2"
T. equiperdum is a convenient test organism in that the in vitro
assay can be made to correspond to the in vivo conditions. These tests
are complemented by the reliable infectivity of the organism for small
laboratory animals. The organism can be safely carried in guinea pigs
and is inevitably fatal to mice. The appearance of any complete cures
can be regarded with confidence since no controls ever survive beyond
4 days.
The dual culture technic did give effects which were widely different
at the two temperatures for some drugs and identical for others. The
specific instances will be discussed later in dealing with the drugs but
it may be mentioned here that this difference was frequently inde-
pendent of surface tension differences at these same two temperatures.
Penicillic acid, for instance, which has significantly different surface
effects at the two test temperatures, has identical trypanocidal effects.
This seems to indicate that such a drug acts directly on the organisms
and that the reproductive or metabolic cycles are not of cardinal im-
portance to the mode of action.
There are several important uncontrolled variables in the trypano-
some methods used in this study. The most important is the lack of
standard serum source. Pooled human serum, including that of hospital
patients and luetics, undoubtedly has unpredictable components. The
complete failure of some batches to support growth probably indicates
a significant concentration of some arsenical. Since this situation does
occur occasionally to such an extent that growth is completely inhibited,
it might be reasonable to consider that subinhibitory concentrations
existed in some sera which did permit trypanosome growth. The
possibility that such amounts might have a synergistic effect with some
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ofthe testcompounds is not ruled out. This difficulty might be solved by
using serum from one individual. This is obviously difficult and presents
another problem. Yorke showed that the inhibitory substances in the
blood of different individuals varied significantly. The other possibility
is the use of animal serum, but a large animal is needed for the large
numbers of tests to be done, and this cancels the benefit of working
with a system related to human physiology.
The second difficulty lay in the method of reading results. The
quantitative nature of the assaywould be improved if exact trypanosome
counts could be made. This would sharply curtail the number of tests
done at any one time and it would introduce additional time variables.
It seemed more important to evaluate a large series of compounds in a
single experiment and to replicate results with additional assays.
In the in vivo test the major difficulty lay in assuming uniformity in
the mice of different experiments. Although mice of the same age, sex,
and weight were used each time, it was not possible to obtain close
similiarity among trials. Since it is known that survival time of try-
panosome-infected mice varies with sex and age and not significantly
withweight,23 adegreeofintra-experimental variation proved inevitable.
This variability was increased by using death time as an end point.
Since no constant watch was kept on the infected and on the treated
mice, exact death times were not ascertainable, especially when mice
died at night. Experiments were set up in such a way that most of the
controls would die during the day. This accounted, at least in part, for
the greater variance of treated mice whose average death times could
not be so accurately predicted.
From the work of Chen8 previously mentioned, in which he showed
the perfectly geometric progression of trypanosome growth in mice,
it is difficult to understand variability in similarly infected mice. It
should be noted that he used very large and very homogeneous numbers
of mice and that he interpolated his curves at both ends. Morrell23
showed that the variability lay at the end of the parasitemia. That is,
trypanosome counts reach a similar maximum in all the mice, but some
mice live longer with this maximum than do others. The calculation of
the significance of the differences in survival times takes into considera-
tion all the total variances involved so that theprobabilities recorded are
conservative.
The fine curves that Chen proposed tempt one to relate the increase
in survival time with theproportion oforganismsdestroyed. Since within
the log growth period of trypanosomes in mice survival is a function
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of the actual numbers of organisms and since this log growth period is
practically unmodified during the life of the host, the number of
organisms responsible for death at a certain interval seems clearly
predictable. If such a calculation is made on the basis of 5 mice each in
the control and treated groups, it would appear that a drug has to kill
all but 5 of the million organisms with which the animal is inoculated
before the minimum level of statistical significance is reached. Such a
figure is not inconceivable, since it can be observed directly that a short
time after an effective injection of 2-pentene-1,4-olid no organisms can
be found in the blood stream for at least 24 hours even if the blood
swarmed with trypanosomes a short time before.
From his calculations Chen concluded that there was no evidence
of an immune response within the period he studied and his evidence
is convincing. For the practical purposes of this study and because of the
lack of contrary evidence, no humoral factors can be considered opera-
tive. Ifall butaveryfeworganisms arekilled and yet the mouse does not
survive, it may be reasoned that in another host where the responses of
humoral mechanisms to these organisms are better developed, a drug
which in the former serves only to increase survival time might in the
latter provide a complete cure.
Using mice as test animals has the advantage that prolongation of
life is strictly a function of the trypanocidal effect of the drug. On the
other hand, drugs which might be actually curative in animals with
highly developed natural defenses are here not even statistically
significant, if for instance only 99.9 per cent of the trypanosomes were
destroyed.
The basic requirements for biological activity in heterocyclic com-
pounds are summarized by Veldstra33 in the following characteristics:
I. A basal ring system with high surface activity and at
least one double bond.
II. A carboxyl group or its dipole (or a structure serving a
similar function) in a very definite spatial position with
respect to the ring system.
These observations resulted from study in which chemical structure was
the main variable. Attempts to rationalize the results consisted of com-
paring structures, or the physical or chemical properties related to them,
with their effect in a complete biological system.
In general, these changes appear to affect two separate mechanisms
of action. Veldstra was fortunate in that his system clearly distinguishes
between the two functions. First, the successful approach of the agent
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to a selected position in the physical or chemical anatomy of the test
organism, accomplished by what Rideal calls surface penetration, was
measured by interfacial tension changes. The second mechanism affects
susceptible enzyme systems or other vital structures. The relative im-
portance of these mechanisms will depend upon the nature and location
of the structure ultimately affected.
In the present study, as in most chemotherapeutic trials, it is difficult
to tell which mechanism is enhanced by which structural change. An
attempt to elucidate this problem was made by the measurement of
surface tension effects. These were carried out at an air-water interface,
which represents a rather generalized condition and is frequently
inadequate. As has been previously pointed out, Rideal demonstrated
that interfacial tension effects are important chiefly in relation to the
nature of the phases.
The characteristics of biological activity as defined by Veldstra
would deal almost exclusively with film penetration if they are con-
sidered in the light of Rideal's studies. The first characteristic, that of
an unsaturated surface-active ring structure, obviously concerns pene-
tration. Veldstra proved this even further by polarographic studies of
unsaturated compounds. He deduced that the number and position of
double bonds had little to do with reactivity but were important in
adding to surface tension effects.
In this regard Rideal has demonstrated that the presence of a
hydrogen donating group and the surrounding apolar group, which
affects its lability, are responsible for the ability of a substance to adsorb
onto the active portions of a protein. Just as in the case of film penetra-
tion, this is another aspect of "approach" and does not in itself guarantee
biological activity.
In this presentstudy it can be seen that the lactones and their analogs
have a definite related pattern of biological activities. The order of their
in vitro effects from most to least active are against:
1. trypanosomes,
2. erythrocytes (hemolysis),
3. gram-negative bacteria (Shigelladysenteriae),
4. gram-positive bacteria (Staphylococcus aureus).
It has been shown here that the ability of an agent to lower surface
tension at an air-water interface does not determine the level of effect,
even in hemolysis.
The relation of structure to activity in this series is in general
accordwithVeldstra's requirements. The active lactones arecharacterized
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by a Y or 6 ring with a carbonyl group capable of acting as a hydrogen
donator. Unsaturation in either type of ring significantly increases
activity. In the case of the 8 lactones, a multiple conjugated system of
double bonds increases activity even more. In keeping with an earlier
observation, the introduction of unsaturated linkages increases the
surface tension effect.
Substituent groups which do not themselves lend activity (e.g.,
penicillic acid) serve almost invariably to depress it. This is in keeping
with Rideal's observation that side chains depress interfacial penetrating
ability.
From the nature of the structural changes, it would appear that the
effects were chiefly on "approach" mechanisms. It is more difficult to
understand the importance of the position of the double bond in the
angelicalactones, especially since their surface effects are identical. It
is possible that their power to penetrate different types of interfaces
would vary. A possible indication of this is found in the greater toxicity
of 2-pentene-1,4-olid over its bond isomer. That some selective property
has been affected is seen in the fact that the 3-pentene-1,4-olid remains
more effective against bacteria.
The importance of bond position in relation to activity is more im-
pressive in the clavacin lactones. Although a parallel relation of
activity to surface tension effect is visible in this comparison, the very
great magnitude of difference suggests a more specific mechanism. Such
afifty-fold difference is reminiscent of an anomalous effect discovered by
Eagle in his study of the phenylarsenoxides."2 Para-arsenophenylbutyric
acid contrasts remarkably with other members of the homologous series.
It is possible that this compound as well as clavacin has come upon some
specific mechanism, either of enzyme inhibition or of metabolite
antagonism. The variations in film penetrating activity cause relatively
minor effects where a specific mechanism is encountered. It is also
possible that many analogous structures have similar potentials but are.
kept from the full exercise of their properties by lacking the ability to
reachanoptimum position. Itis in this latter sense that such variations as
may affect "approach" become of great importance. The in vitro differ-
ence between 2- and 3-pentene-1,4-olid, though small and probably
related to penetration, is sufficient to make the essential difference of
therapeutic efficacy.
Enhanced in vitro activity is not necessarily paralleled by in vivo
effect. Clavacin, though it has the same order of trypanocidal activity
as do the arsenicals, is quite worthless in vivo. Here enhanced activity
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also means greater toxicity with implied loss of specificity. The same
applies to anemonine, which is far more effective than is 2-pentene-1,4-
olid in vitro but does nothing to protect the infected animal.
The activity of the furans similarly satisfies Veldstra's requirements.
Only the unsaturated rings are active and activity increases with the
hydrogen donating ability of the side chain.
Relatively low in vitro activity among the furans is sometimes
complemented by permanent cures in mice. The remarkable powers of
furacin, a nitro derivative, may indicate that the furans have an in-
trinsic and rather specific trypanocidal effect. It is to be regretted that no
nitro-lactones could be obtained for comparative study.
Furacin is interesting not only because of its striking therapeutic
properties but also in view of its very low toxicity. Even the furans
having very little trypanocidal activity are much more toxic. This is a
concrete illustration of the fact that toxicity and trypanocidal activity
do not reside in the same structures and that the two activities are
separable. Similarly there are several examples that would indicate that
antibacterial effect and trypanocidal effect are separable. Methyl sub-
stitutions, for instance, in the furans are effective in reducing anti-
bacterial activity but they do not influence trypanocidal effect in vitro.
A similar relationship of effects is obtained by adding methyl groups to
3-pentene-1,4-olid.
Although saturated lactones have no appreciable trypanocidal
activity, their interesting toxicities and their possible antiviral activity
depart from Veldstra's ideas about fundamental biological activity. This
may be a case in which the level of activity is so superficial or so
accessible that the surface activity conferred by unsaturation is un-
necessary. Lack of trypanocidal effect is interesting when we consider a
similar lack of activity of arsenicals to which the organism has become
resistant. The evidence in the case of arsenic resistance clearly indicates
that absorption can determine whether or not a drug is effective.
Arsenicals, such as phenylarsenoxides, that can be made to enter (possi-
bly by another route) are just as effective as are the original arsenicals
for a non-resistant trypanosome strain. Mode of entry is then perhaps a
more important barrier in trypanosomes than in cells more susceptible
to the saturated lactones.
Summaryandconclusions
1. A total of forty-four compounds of an analogous series related
to antibiotic lactones were examined for in vitro and in vivo trypanocidal
activity.
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2. The in vitro assay was a modification of Yorke's method for
cultivation of trypanosomes at 370 C. using an inactivated human blood
serum base. Therapeutic trials were done in mice and the effects were
calculated statistically when permanent cures were not effected.
3. Activity in the series depended on the size of the basic ring, the
nature of the side chains, and the number and position of unsaturated
linkages.
4. Delta lactones were more active than gamma lactone analogs.
Most side chains reduced activity. More unsaturated linkages increased
activity. Three lactones had significant in vivo effect: 2-pentene-1,4-olid,
penicillic, and coumalinic acids. In vivo activity did not correlate with
in vitro effect.
5. Three furans were significantly active in vivo: furfural, furfuryl
alcohol, and furacin. The last could cure 100 per cent of the mice with
a single oral dose of low toxicity. Hydrogenated furans were inactive.
6. Nitrogen analogs were toxic and inactive in vivo.
7. Antibacterial and toxic effects of the forty-four agents were not
quantitatively related to trypanocidal activity.
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